Shares of Plexus Corp. (NASDAQ:PLXS – Get Free Report) have been given an average rating of “Hold” by the five analysts that are covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $125.25.
PLXS has been the subject of several research reports. KeyCorp began coverage on Plexus in a research report on Tuesday. They set a “sector weight” rating for the company. Needham & Company LLC upped their price target on Plexus from $114.00 to $144.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Finally, Benchmark restated a “buy” rating and set a $150.00 price objective on shares of Plexus in a research report on Monday.
View Our Latest Analysis on Plexus
Insider Activity
Hedge Funds Weigh In On Plexus
A number of institutional investors and hedge funds have recently added to or reduced their stakes in PLXS. AlphaMark Advisors LLC bought a new position in Plexus in the 1st quarter valued at about $267,000. Principal Financial Group Inc. lifted its stake in Plexus by 0.3% during the first quarter. Principal Financial Group Inc. now owns 151,190 shares of the technology company’s stock valued at $14,336,000 after buying an additional 387 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of Plexus by 13.8% in the first quarter. BNP Paribas Financial Markets now owns 25,424 shares of the technology company’s stock worth $2,411,000 after buying an additional 3,087 shares during the period. Capstone Investment Advisors LLC acquired a new stake in shares of Plexus during the first quarter valued at approximately $216,000. Finally, Farrow Financial Inc. lifted its position in shares of Plexus by 7.3% in the 1st quarter. Farrow Financial Inc. now owns 21,370 shares of the technology company’s stock valued at $2,026,000 after acquiring an additional 1,446 shares in the last quarter. 94.45% of the stock is owned by institutional investors.
Plexus Price Performance
Shares of PLXS opened at $144.89 on Tuesday. Plexus has a twelve month low of $87.21 and a twelve month high of $153.60. The company has a market cap of $3.95 billion, a price-to-earnings ratio of 36.50 and a beta of 0.89. The company has a quick ratio of 0.64, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company has a 50 day moving average of $130.48 and a two-hundred day moving average of $115.82.
Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.30. The business had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.01 billion. Plexus had a return on equity of 9.64% and a net margin of 2.82%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.44 EPS. As a group, analysts predict that Plexus will post 3.74 earnings per share for the current fiscal year.
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
- Five stocks we like better than Plexus
- How to Invest in Biotech Stocks
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What Does Downgrade Mean in Investing?
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Stock Splits, Do They Really Impact Investors?
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.